Unlocking the potential of cancer treatment with CRISPR gene editing system

Cancer, the second leading cause of death worldwide, presents significant social, public health, and financial challenges in the last century. Breast cancer has emerged as the most common type of cancer. Developing innovative, cost-effective, safe diagnostic, and therapeutic options to combat relapse and drug resistance in cancer treatment is crucial. Gene therapy, particularly CRISPR/Cas 9, has emerged as a promising therapeutic approach for cancer treatment. The CRISPR/Cas 9 system provides a simple, cost-effective, and highly specific method for genome editing, making it an attractive tool for breast cancer treatment. While the CRISPR/Cas 9 system raises social, ethical, and safety concerns, its potential for gene therapy is promising. It is expected that CRISPR/Cas 9-based techniques will become a more effective strategy for future gene therapy to address the complexities of various tumors and cancer drug resistance. This study explores the potential of CRISPR/Cas 9 gene therapy in modifying oncogenic genome and epigenome distortions, targeting specific genes involved in breast cancer, and overcoming drug resistance.

Unlocking the potential of cancer treatment with CRISPR gene editing system Keywords:

CRISPR , Cancer , Breast cancer , CRISPR/Cas 9